HLB바이오스텝
5,250KRWMarket close of 10/29 (Thu)
Down -11.17%-660KRWMarket close of 10/29 (Thu)
- Open
- 6,000
- High
- 6,070
- Low
- 5,220
- Day range
- Day range low 5,220 high 6,070, open 6,000, close 5,250, previous close 5,910
- Volume
- 57×10K shares
- 3.1B KRW 0.28× the 20-session average
Market close of 10/29 (Thu)
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/29 (Thu)
Market close data of 2026-10-29Points to check
- Earningsto check-8.7B KRWOperating income over the last four quarters -8.7B KRW (loss)
- Daily movenot verifiedOnly 21 daily bars to compare, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
The other 2
- Foreign & institutionalnot verified
- Trading value0.3×usual range
With 21 trading days, the 1-year position isn't calculated · First data date 9/29 (Tue)
See the full check report
Quarterly results · Q1 2026
- Revenue13.5B KRW
- vs. year ago
- -0.7%
- vs. prior quarter
- -28.0%
- Operating income-2.6B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-19.4%
- vs. year ago
- -0.6 pp
- vs. prior quarter
- -7.5 pp
Quarterly operating income trend
As of the latest official close · 2026-10-29Valuation filing date · 2026-05-15Same sector · 바이오 R&D
Down -1.23%· 9 of 64 stocks up, preferred shares excluded · trading value 195.6B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -13.6% | Down -1.35% | 51.8B KRW |
| SK바이오팜 | Close over the last 20 sessions +4.6% | Up +3.46% | 16.0B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -0.4% | Down -2.80% | 15.7B KRW |
| 올릭스 | Close over the last 20 sessions -5.9% | Down -0.82% | 14.9B KRW |
| 리가켐바이오 | Close over the last 20 sessions -19.8% | Down -3.32% | 14.5B KRW |
Schedule
- Next data 11/2 (Mon) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 86% of trading value, about 93% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.